Treatment of painful diabetic neuropathy: A review of the most efficacious pharmacological treatments

L. C. Rogers, U. Alam, Rayaz Malik, S. Tesfaye

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Painful diabetic neuropathy is a common and troubling complication of diabetes. Many current treatments are based on anecdotal reports or relatively small clinical trials in which the efficacy of the agents is questionable, reflecting the fact that none is specifically licensed for the management of painful diabetic neuropathy. Despite these limitations the authors provide a practical algorithm based on a number needed to treat analysis together with an assessment of drug safety. We advocate an improvement in overall glycaemic control together with a reduction in glucose flux, coupled with a stepwise approach starting with a tricyclic, followed by gabapentin, tramadol and carbamazepine. We do not recommend combination treatment.

Original languageEnglish
Pages (from-to)301-306
Number of pages6
JournalPractical Diabetes International
Volume21
Issue number8
DOIs
Publication statusPublished - Oct 2004
Externally publishedYes

Fingerprint

Diabetic Neuropathies
Pharmacology
Tramadol
Numbers Needed To Treat
Carbamazepine
Diabetes Complications
Clinical Trials
Safety
Glucose
Pharmaceutical Preparations
gabapentin

Keywords

  • Diabetes
  • Neuropathy
  • Pain
  • Treatment

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Treatment of painful diabetic neuropathy : A review of the most efficacious pharmacological treatments. / Rogers, L. C.; Alam, U.; Malik, Rayaz; Tesfaye, S.

In: Practical Diabetes International, Vol. 21, No. 8, 10.2004, p. 301-306.

Research output: Contribution to journalReview article

@article{f61d63086a0946448fae7983d99244df,
title = "Treatment of painful diabetic neuropathy: A review of the most efficacious pharmacological treatments",
abstract = "Painful diabetic neuropathy is a common and troubling complication of diabetes. Many current treatments are based on anecdotal reports or relatively small clinical trials in which the efficacy of the agents is questionable, reflecting the fact that none is specifically licensed for the management of painful diabetic neuropathy. Despite these limitations the authors provide a practical algorithm based on a number needed to treat analysis together with an assessment of drug safety. We advocate an improvement in overall glycaemic control together with a reduction in glucose flux, coupled with a stepwise approach starting with a tricyclic, followed by gabapentin, tramadol and carbamazepine. We do not recommend combination treatment.",
keywords = "Diabetes, Neuropathy, Pain, Treatment",
author = "Rogers, {L. C.} and U. Alam and Rayaz Malik and S. Tesfaye",
year = "2004",
month = "10",
doi = "10.1002/pdi.703",
language = "English",
volume = "21",
pages = "301--306",
journal = "Practical Diabetes",
issn = "2047-2897",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Treatment of painful diabetic neuropathy

T2 - A review of the most efficacious pharmacological treatments

AU - Rogers, L. C.

AU - Alam, U.

AU - Malik, Rayaz

AU - Tesfaye, S.

PY - 2004/10

Y1 - 2004/10

N2 - Painful diabetic neuropathy is a common and troubling complication of diabetes. Many current treatments are based on anecdotal reports or relatively small clinical trials in which the efficacy of the agents is questionable, reflecting the fact that none is specifically licensed for the management of painful diabetic neuropathy. Despite these limitations the authors provide a practical algorithm based on a number needed to treat analysis together with an assessment of drug safety. We advocate an improvement in overall glycaemic control together with a reduction in glucose flux, coupled with a stepwise approach starting with a tricyclic, followed by gabapentin, tramadol and carbamazepine. We do not recommend combination treatment.

AB - Painful diabetic neuropathy is a common and troubling complication of diabetes. Many current treatments are based on anecdotal reports or relatively small clinical trials in which the efficacy of the agents is questionable, reflecting the fact that none is specifically licensed for the management of painful diabetic neuropathy. Despite these limitations the authors provide a practical algorithm based on a number needed to treat analysis together with an assessment of drug safety. We advocate an improvement in overall glycaemic control together with a reduction in glucose flux, coupled with a stepwise approach starting with a tricyclic, followed by gabapentin, tramadol and carbamazepine. We do not recommend combination treatment.

KW - Diabetes

KW - Neuropathy

KW - Pain

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=13344277932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13344277932&partnerID=8YFLogxK

U2 - 10.1002/pdi.703

DO - 10.1002/pdi.703

M3 - Review article

AN - SCOPUS:13344277932

VL - 21

SP - 301

EP - 306

JO - Practical Diabetes

JF - Practical Diabetes

SN - 2047-2897

IS - 8

ER -